AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
Jinfen Wang(Shanxi Provincial Cancer Hospital), Ken H. Young(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Wayne Tam(Cornell University), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Yong Li(Baylor College of Medicine), Jing Wang(The University of Texas MD Anderson Cancer Center), Shi Wang(National University Hospital), Qi Shen(University of Illinois Chicago), Kausar J. Jabbar(Beaumont Health), L. Jeffrey Medeiros(Delaware Division of Libraries), Lan V. Pham(Pharmacyclics (United States)), Michael Møller(Hospital South West Jutland)
Cited by 60
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k